Heparin
Articles · Lactation Safety Information · Published , updated
84812008
Articles
18th September 2020
Safety in Lactation: Drugs for thromboembolic disorders
Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Oral anticoagulants The coumarin anticoagulants, warfarin… Abciximab Acenocoumarol Alteplase Apixaban Argatroban Aspirin Cardiovascular system disorders Clopidogrel Dabigatran etexilate Dalteparin Dipyridamole Edoxaban Enoxaparin Epoprostenol Eptifibatide Fondaparinux Heparin Phenindione Prasugrel Rivaroxaban Safety in Lactation Ticagrelor Tinzaparin Urokinase Warfarin
14th September 2020
What factors should be considered when using LMWH to treat venous thromboembolism in patients with high body weight?
Treatment of venous thromboembolism (VTE) in patients with high body weight constitutes a challenge in clinical practice. Adjustments in the dose calculation may be necessary… Cardiovascular system disorders Dalteparin Enoxaparin Heparin Q&A Tinzaparin
11th February 2019
Maintaining Patency of Central Venous Catheters in Adults: RMOC Position Statement
The Regional Medicines Optimisation Committee (RMOC) (London) reviewed the role of heparinised saline lock versus sodium chloride 0.9% lock for maintaining patency of central venous… Heparin RMOC medicines optimisation recommendations and resources RMOC new medicines recommendation Sodium chloride
18th October 2018
How should medicines be dosed in children who are obese?
Obesity results in physiological changes that can affect the volume of distribution and the clearance of drugs. The extent of these changes is variable and… Aciclovir Aminophylline Benzylpenicillin Carbamazepine Clindamycin Enoxaparin Esomeprazole Gentamicin Heparin Ibuprofen Metronidazole Morphine Omeprazole Ondansetron Paediatric and neonatal medicine Paracetamol Phenobarbital Phenobarbital sodium Phenoxymethylpenicillin Phenytoin Phenytoin sodium Prednisolone Q&A Ranitidine Theophylline Tobramycin Vancomycin
14th September 2016
Common Questions and Answers on the Practical Use of Oral Anticoagulants in Non-Valvular Atrial Fibrillation (Jan 2016)
Please note – the content of this resource has not been updated since the publication date. Some information may be out of date and links… Acute Care Apixaban Dabigatran etexilate Edoxaban Heparin Medicine Primary Care Rivaroxaban Warfarin
30th July 2010
ARCHIVED NPSA Alert – Reducing treatment dose errors with low molecular weight heparins 2010
This page forms part of a resource on medication related patient safety alerts issued by the National Patient Safety Agency (NPSA) between 2002 and 2012… Dalteparin Enoxaparin Heparin Medicines Safety Tinzaparin
24th April 2008
ARCHIVED NPSA Alert – Intravenous heparin flush solutions 2008
This page forms part of a resource on medication related patient safety alerts issued by the National Patient Safety Agency (NPSA) between 2002 and 2012… Heparin Medicines SafetyLactation Safety Information
-
No published evidence of safety
Extensive experience of safe use in breastfeeding
Low levels anticipated in milk due to the drug’s properties and not absorbed from the infant’s GI tract
Used in full-term neonates from birth
30th July 2020